Keros Therapeutics Inc to Host Conference Call Transcript
Good morning, and welcome to the Keros Therapeutics 2023 American Society of Hematology Annual Meeting Update Call. (Operator Instructions) Later, we will conduct a question-and-answer session and instructions on how to ask a question will follow at that time. As a reminder, this call will be recorded and the link to the recording will be available on Keros's corporate website.
I would now like to introduce your host for today's program, Justin Frantz, Keros's Head of Investor Relation. Mr. Frantz, please go ahead.
Thank you, operator. Thank you all for joining us on today's call. As we announced this morning, we are very excited to report clinical updates from our hematology franchise, a press release is available on our website at Claros Tx.com and is also included as an exhibit in the Form 8-K we filed with the Securities and Exchange Commission during this call, we will be making a number of forward-looking statements. Please take a moment to review our disclaimer slide on the webcast, which
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
